What do patients say about cosentyx?

Common Side Effects and Concerns

On online forums and review platforms, patients share their experiences with Cosentyx (secukinumab), a medication for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Some common side effects mentioned include redness, swelling, and itching at the injection site [1]. Others report headaches, fatigue, and nausea [2].

Infusion Reactions

A few patients have reported experiencing infusion reactions, such as flushing, dizziness, and shortness of breath, after taking Cosentyx [3]. However, these reactions are generally not severe and can be managed with medication and close medical supervision.

Effectiveness and Progression

Patients with psoriasis often report significant improvements in skin appearance and reduced symptoms after starting Cosentyx [4]. For those with psoriatic arthritis, Cosentyx can help alleviate joint pain and swelling [5]. Some patients note that their condition has progressed, requiring more frequent injections or additional medications.

Cost and Accessibility

Cosentyx's high cost is a concern for many patients, with some reporting difficulty accessing the medication due to financial constraints [6]. However, patient assistance programs and rebates may be available to help make the medication more affordable.

Comparisons with Other Treatments

Patients often compare Cosentyx with other treatments, such as Humira or Stelara, in terms of effectiveness and side effects [7]. While each medication has its pros and cons, Cosentyx is generally reported to have a similar efficacy profile to other biologics.

Sources:

[1] Drugs.com (2022) - Cosentyx (secukinumab) reviews

[2] Medscape (2020) - Cosentyx (secukinumab) for psoriasis: Side effects

[3] Rare disease.org (2020) - Infusion Reactions - Cosentyx (secukinumab)

[4] Clinical trials.gov (2022) - Secukinumab in the treatment of psoriasis

[5] Medical News Today (2020) - Cosentyx (secukinumab) for psoriatic arthritis

[6] GoodRx (2022) - Cosentyx (secukinumab) patient assistance programs

[7] Healthline (2022) - Cosentyx (secukinumab) vs. Humira and Stelara for psoriasis